Citations

Showing 10 of 108094 citations.

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials
Rutherford, Sarah C. , Yin, Jun , Pederson, Levi , Burbano, Gabriela Perez , LaPlant, Betsy, Kenkre, Vaishalee P. , Hong, Fangxin , Blum, Kristie A. , Dockter, Travis , Martin, Peter , Grant, Barbara, Rosenbaum, Cara A. , Ujjani, Chaitra S. , Cheson, Bruce D. , Bartlett, Nancy L. , Friedberg, Jonathan W. , Mandrekar, Sumithra J. , Leonard, John P. , Perez Burbano, Gabriela, Hong, Fangxin , Blum, Kristie A , Dockter, Travis , Martin, Peter , Jung, Sin‐Ho , Rosenbaum, Cara , Barr, Paul M , Unger, Joseph M , Cheson, Bruce D , Bartlett, Nancy L , Kahl, Brad S , Mandrekar, Sumithra J , Shadman, Mazyar , Li, Hongli , LeBlanc, Michael , Barr, Paul M. , Unger, Joseph M. , Kahl, Brad S.

Mayo Clinic

Journal of Clinical Oncology | July 5, 2022 | Volume: 41 | Issue: 2 | Pages: 336-342

10.1200/jco.21.02301 | PMID 35787017 Get It

PURPOSE Bone marrow biopsies (BMB) are performed before/after therapy to confirm complete response (CR) in patients with lymphoma on clinical trials. We sought to establish whether BMB add value in assessing response or predict progression-free survival (PFS) or overall survival (OS) outcomes in follicular lymphoma (FL) subjects in a large, multicenter, multitrial cohort. METHODS Data were pooled from seven trials of 580 subjects with previously untreated FL through Alliance for Clinical Trials in Oncology (Alliance) and SWOG Cancer Research Network (SWOG) completing enrollment from 2008 to 2016. RESULTS Only 5/580 (0.9%) had positive baseline BMB, CR on imaging, and subsequent positive BMB ( P < .0001). Therefore, BMB were irrelevant to response in 99% of subjects. A sensitivity analysis of 385 FL subjects treated on an Eastern Cooperative Oncology Group study was included. In the Eastern Cooperative Oncology Group cohort, 5/385 (1.3%) had BMB that affected response assessment. Since some subjects do not undergo confirmatory BMB, we performed a landmark survival analysis from first radiologic CR with data from 580 subjects from Alliance and SWOG. Of subjects with CR on imaging (n = 187), PFS and OS were not significantly different among those with negative BMB to confirm CR (n = 47) versus those without repeat BMB (n = 140; PFS: adjusted hazard ratio, 1.10, 95% CI, 0.62 to 1.94, log-rank P = .686; OS: hazard ratio, 0.59, 95% CI, 0.23 to 1.53, log-rank P = .276). CONCLUSION We conclude that BMB add little value to response assessment in subjects with FL treated on clinical trials and we recommend eliminating BMB from clinical trial requirements. BMB should also be removed from diagnostic guidelines for FL except in scenarios in which it may change management including confirmation of limited stage and assessment of cytopenias. This would reduce cost, patient discomfort, resource utilization, and potentially remove a barrier to trial enrollment.
Chemokines in ICU Delirium: An Exploratory Study
Smith, Ryan J. , Cartin‐Ceba, Rodrigo , Lachner, Christian , Trivedi, Shubham , Khatua, Biswajit , Rabinstein, Alejandro A. , Singh, Vijay , Gajic, Ognjen

Mayo Clinic

Critical Care Explorations | July 5, 2022 | Volume: 4 | Issue: 7 | Pages: e0729

10.1097/cce.0000000000000729 | PMID 35815182 Get It

OBJECTIVES: The pathophysiology of delirium is complex and incompletely understood. Inflammation is hypothesized to be integral to its development due to effects on blood brain barrier integrity, facilitation of leukocyte extravasation into brain parenchyma, and propagation of neuroinflammation. Septic shock is the prototypical condition associated with ICU delirium; however, the relative contribution of resultant hypotension and systemic inflammation to the development of delirium is unknown. DESIGN: This was a prospective exploratory study. SETTING: A multidisciplinary ICU at an academic medical center in Phoenix, AZ. PATIENTS: Critically ill patients older than or equal to 18 years old admitted to the ICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Screening for delirium was performed using the Confusion Assessment Method for the ICU tool. The levels of C-C motif ligand 2 (CCL2), C-C motif ligand 3, C-X-C motif chemokine ligand 1, C-X-C motif chemokine ligand 10, and interleukin-8 were measured in serum samples obtained within 12 hours of ICU admission. Univariate and multivariate analyses were performed to assess the association of delirium with patient data pertaining to hospital course, laboratory values, vital signs, medication administration, and levels of the aforementioned chemokines. Forty-one of 119 patients (34.5%) in the study cohort developed ICU delirium. Each chemokine studied was associated with delirium on univariate analyses; however, CCL2 was the only chemokine found to be independently associated with the development of delirium on multivariable analysis. The association of increased CCL2 levels with delirium remained robust in various models controlling for age, presence of shock, Sequential Organ Failure Assessment score, Acute Physiology and Chronic Health Evaluation IV score, mean arterial pressure at presentation, lowest mean arterial pressure, and total opioid, midazolam, propofol, and dexmedetomidine exposure. CONCLUSIONS: The demonstrated relationship between CCL2 and delirium suggests this chemokine may play a role in the development of delirium and warrants further investigation.
Charting the meningeal lymphatic network
Mesquita, Sandro Dá , Da Mesquita, Sandro

Mayo Clinic

Journal of Experimental Medicine | July 5, 2022 | Volume: 219 | Issue: 8 | Pages: No page available

10.1084/jem.20220891 | PMID 35789368 Get It

A genuine network of lymphatic vessels can be found in the dural layer of the meninges that ensheathe the brain and spinal cord of mammalians. In this issue, Jacob et al. (2022. J. Exp. Med.https://doi.org/10.1084/jem.20220035) employ light sheet fluorescence imaging of intact mouse heads to provide a more comprehensive chart of the meningeal lymphatic vasculature and draw a parallel between lymphatic drainage of cerebrospinal fluid in mice and humans.
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline
Eastham, James A., Boorjian, Stephen A. , Kirkby, Erin

Mayo Clinic

Journal of Urology | July 5, 2022 | Volume: 208 | Issue: 3 | Pages: 505-507

10.1097/ju.0000000000002854 | PMID 35830561 Get It

Diagnosis and Treatment of Combined Pulmonary Fibrosis and Emphysema in 2022
Nemoto, Masahiro , Koo, Chi Wan , Ryu, Jay H. , Ryu, Jay H , Nemoto, Masahiro

Mayo Clinic

JAMA | July 5, 2022 | Volume: 328 | Issue: 1 | Pages: 69

10.1001/jama.2022.8492 | PMID 35788808 Get It

Analysis of Registered Clinical Trials in Gastroenterology, 2007-2019
Perera, Nirosha D. , Kamceva, Marija , Shen, Jolie , Turner, Brandon E. , Abdou, Maya , Turner, Brandon E , Steinberg, Jecca R , Mahipal, Amit

Mayo Clinic

JAMA Network Open | July 5, 2022 | Volume: 5 | Issue: 7 | Pages: e2221770

10.1001/jamanetworkopen.2022.21770 | PMID 35788673 Get It

Primary Fixation and Cyclic Performance of Single-Stitch All-Inside and Inside-Out Meniscal Devices for Repairing Vertical Longitudinal Meniscal Tears
Bachmaier, Samuel , Krych, Aaron J. , Smith, Patrick A. , Herbort, Mirco , Ritter, Daniel, LaPrade, Robert F. , Krych, Aaron J , LaPrade, Robert F , Wijdicks, Coen A.

Mayo Clinic

The American Journal of Sports Medicine | July 5, 2022 | Volume: 50 | Issue: 10 | Pages: 2705-2713

10.1177/03635465221107086 | PMID 35787211 Get It

Background: Primary device fixation and the resistance against gap formation during repetitive loading influence the quality of meniscal repair. There are limited biomechanical data comparing primary tensioning and cyclic behavior of all-inside versus inside-out repair. Hypothesis: All-inside devices provide higher initial load on the meniscal repair than inside-out fixation, and stiffer constructs show higher resistance against gap formation during cyclic loading. Study Design: Controlled laboratory study. Methods: In total, 60 longitudinal bucket-handle tears in human cadaveric menisci were created and repaired with a single stitch and randomly assigned to 4 all-inside groups (TrueSpan, FastFix 360, Stryker AIR, FiberStich) and 2 inside-out groups (suture repair [IO-S], suture tape [IO-ST]). Residual load after repair tensioning (50 N) and relief displacement were measured. Constructs underwent cyclic loading between 2 and 20 N over 500 cycles (0.75 Hz) with cyclic stiffness, gap formation, and final peak elongation measured. Ultimate load and stiffness were analyzed during pull to failure (3.15 mm/s). Results: All-inside repair demonstrated significantly higher primary fixation strength than inside-out repair. The significantly highest load (mean ± SD; 20.1 ± 0.9 N; P < .037) and relief displacement (–2.40 ± 0.32 mm; P < .03) were for the knotless soft anchoring FiberStich group. The lowest initial load (9.0 ± 1.5 N; P < .001) and relief displacement (–1.39 ± 0.26 mm; P < .045) were for the IO-S repair group. The final gap formation (500th cycle) of FiberStich (0.75 ± 0.37 mm; P < .02) was significantly smaller than others and that of the IO-S (1.47 ± 0.33 mm; P < .045) significantly larger. The construct stiffness of the FiberStich and IO-ST groups was significantly greater at the end of cyclic testing (16.7 ± 0.80 and 15.5 ± 1.42 N/mm; P < .042, respectively) and ultimate failure testing (23.4 ± 3.6 and 20.6 ± 2.3 N/mm; P < .005). The FastFix 360 (86.4 ± 4.8 N) and Stryker AIR (84.4 ± 4.6 N) groups failed at a significantly lower load than the IO-S group ( P < .02) with loss of anchor support. The FiberStich (146.8 ± 23.4 N), TrueSpan (142.0 ± 17.8 N), and IO-ST (139.4 ± 7.3 N) groups failed at significantly higher loads ( P < .02) due to suture tearing. Conclusion: Overall, primary fixation strength of inside-out meniscal repair was significantly lower than all-inside repair in this cadaveric tissue model. Although absolute differences among groups were small, meniscal repairs with higher construct stiffness (IO-ST, FiberStich) demonstrated increased resistance against gap formation and failure load. Clinical Relevance: Knotless single-stitch all-inside meniscal repair with a soft anchor resulted in less gapping, but the overall clinical significance on healing rates remains unclear.
Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylation
Shimada, Shino , Ng, Bobby G. , White, Amy , Nickander, Kim K., Turgeon, Coleman , Liedtke, Kristen, Lam, Christina , Font–Montgomery, Esperanza , Peck, Dawn , Uhles, Crescenda L , Haynes, Devon , Wheeler, Patricia G. , Bamshad, Michael J. , Nickerson, Deborah A. , Cushing, Tom, Gates, Ryan , Gomez‐Ospina, Natalia , Scalco, Fernanda B. , Martinez, Noelia Nunez, Sachdev, Rani , Malone, Stephen , Harris, Rebekah V. , Scheffer, Ingrid E. , Rosenzweig, Sergio D. , Adams, David R. , Gahl, William A. , Malicdan, May Christine V. , Raymond, Kimiyo , Wolfe, Lynne A. , Jarvik, Gail P. , White, Amy L , Liedtke, Kristen L, Peck, Dawn S, Harris, Rebekah V , Scheffer, Ingrid E , Malicdan, May Christine V , Raymond, Kimiyo M, Jarvik, Gail P , Ng, Bobby G , Lourenco, Charles , He, Miao , Umaña, Luis Alfredo , Byers, Heather M. , Smith, Lacey A. , Poduri, Annapurna , Freeze, Hudson H.

Mayo Clinic

Journal of Medical Genetics | July 5, 2022 | Volume: 59 | Issue: 11 | Pages: 1104-1115

10.1136/jmedgenet-2021-108177 | PMID 35790351 Get It

Purpose To summarise the clinical, molecular and biochemical phenotype of mannosyl-oligosaccharide glucosidase-related congenital disorders of glycosylation (MOGS-CDG), which presents with variable clinical manifestations, and to analyse which clinical biochemical assay consistently supports diagnosis in individuals with bi-allelic variants in MOGS. Methods Phenotypic characterisation was performed through an international and multicentre collaboration. Genetic testing was done by exome sequencing and targeted arrays. Biochemical assays on serum and urine were performed to delineate the biochemical signature of MOGS-CDG. Results Clinical phenotyping revealed heterogeneity in MOGS-CDG, including neurological, immunological and skeletal phenotypes. Bi-allelic variants in MOGS were identified in 12 individuals from 11 families. The severity in each organ system was variable, without definite genotype correlation. Urine oligosaccharide analysis was consistently abnormal for all affected probands, whereas other biochemical analyses such as serum transferrin analysis was not consistently abnormal. Conclusion The clinical phenotype of MOGS-CDG includes multisystemic involvement with variable severity. Molecular analysis, combined with biochemical testing, is important for diagnosis. In MOGS-CDG, urine oligosaccharide analysis via matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry can be used as a reliable biochemical test for screening and confirmation of disease.
Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
Larkey, Nicholas E., Ewaisha, Radwa , Lasho, Michael A., Roforth, Matthew M., Granger, Dane, Jerde, Calvin R. , Gorsh, Amy P., Klassen, Stephen A. , Senefeld, Jonathon W. , Joyner, Michael J. , Baumann, N, Theel, Elitza S. , Mills, John R. , Wu, Liang, Gorsh, Amy, Baumann, Nikola A, Theel, Elitza S , Mills, J R , Joyner, Michael J , Senefeld, Jonathon W , Klassen, Stephen A , Wu, Liang Li

Mayo Clinic

Microbiology Spectrum | July 5, 2022 | Volume: 10 | Issue: 4 | Pages: No page available

10.1128/spectrum.01154-22 | PMID 35862939 Get It

COVID-19 convalescent plasma (CCP) was one of the first therapeutic options available for the treatment of SARS-CoV-2 infections and continues to be used selectively for immunosuppressed patients. Given the emergence of novel SARS-CoV-2 variants which are resistant to treatment with available monoclonal antibody (MAb) therapy, CCP remains an important therapeutic consideration.